FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA: 106 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

106

Total FAERS Reports

1 (0.9%)

Deaths Reported

Hospitalizations

106

As Primary/Secondary Suspect

Life-Threatening

Disabilities

First Report: 201105 · Latest Report: 20160602

What Are the Most Common FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA Side Effects?

#1 Most Reported

Drug ineffective

29 reports (27.4%)

#2 Most Reported

Ovarian hyperstimulation syndrome

27 reports (25.5%)

#3 Most Reported

Ovarian cyst

6 reports (5.7%)

Side Effect	Reports	% of Total	Deaths	Hosp.
Drug ineffective	29	27.4%	0	0
Ovarian hyperstimulation syndrome	27	25.5%	1	17
Abdominal distension	6	5.7%	0	4
Ascites	6	5.7%	0	6
Nausea	6	5.7%	0	3
Ovarian cyst	6	5.7%	0	4
Multiple sclerosis relapse	5	4.7%	0	0

Gender: 98.1% female, 1.9% male. Average age: 35.6 years. Most reports from: US. View detailed demographics →

Year	Reports	Hosp.
2011	2	2
2012	2	0
2013	4	2
2014	10	7
2015	38	19
2016	8	1

Indication	Reports
In vitro fertilisation	37
Ovulation induction	19
Product used for unknown indication	14
Infertility	10
Assisted fertilisation	9

Official prescribing information from the FDA-approved drug label.